Caregiver Stress and Sleep Study
Launched by UNIVERSITY OF PITTSBURGH · Jan 21, 2022
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
The Caregiver Stress and Sleep Study is researching how certain therapies can help caregivers who are experiencing stress and depressive symptoms while caring for someone with dementia. In this study, therapists will provide either an experimental treatment aimed at improving mental well-being or a supportive control treatment. The goal is to understand how these approaches affect important health factors, such as morning energy levels, feelings of sadness, and thinking patterns related to depression.
To participate in this study, you need to be at least 60 years old, provide unpaid care to someone living with dementia, and experience stress in your caregiving role. You should not be currently taking medication for depression or undergoing active therapy for mood issues. Participants will go through evaluations, including brain scans, to track changes in their health throughout the study. If you’re interested and meet the criteria, this could be a valuable opportunity to address caregiver stress and improve your overall well-being.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 60 years or older.
- • Provide at least 15 hours/week of unpaid care to a patient with a dementia diagnosis.
- • Reporting stress or strain delivering care
- • No or stable pharmacotherapy for depression
- • Meets screening definition for having morning activation difficulty or a definite morning types per the Composite Morningness Questionnaire (CMQ)
- Exclusion Criteria:
- • Unsafe or unable to undergo MRI
- • Active Cognitive Behavioral Therapy for mood or insomnia
- • Probable dementia diagnosis
- • Deadly illness or plans to leave the study area
- • Current active substance use disorder
About University Of Pittsburgh
The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pittsburgh, Pennsylvania, United States
Patients applied
Trial Officials
Stephen F Smagula, PhD
Principal Investigator
University of Pittsburgh
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials